Fong R S, Beste D J, Murray K J
Department of Otolaryngology and Human Communication, Medical College of Wisconsin, Milwaukee, USA.
Am J Otol. 1995 Nov;16(6):793-6.
In adults, sensorineural hearing loss (SNHL) resulting from megavoltage temporal bone radiation therapy (RT) is dose dependent. A review of the literature reveals only two cases of pediatric SNHL after RT without chemotherapy. This report presents four cases of late onset, asymmetric SNHL after RT in children treated for posterior fossa tumors. The children were treated with surgical resection of the tumor, followed by RT of 50 to 54 gray and no chemotherapy. These children, without evidence of tumor recurrence, developed severe SNHL 18 to 36 months after the completion of RT. Although no definite audiometric pattern was seen, most of the patients had a predominately high frequency SNHL in the poorer hearing ear, and fluctuant hearing in the better ear, without evidence of osteoradionecrosis or otitic infection. A review of the literature suggests that injury to the outer hair cells and cochlear neurons of the basal turn of the cochlea are possible sources for the hearing loss. Pretreatment audiologic evaluation as well as a minimum of 3 years of evaluations following RT would be prudent.
在成人中,兆伏级颞骨放射治疗(RT)导致的感音神经性听力损失(SNHL)与剂量相关。文献综述显示,仅两例接受放疗但未化疗的儿童出现SNHL。本报告介绍了4例接受后颅窝肿瘤治疗的儿童在放疗后出现迟发性、不对称SNHL的病例。这些儿童接受了肿瘤手术切除,随后接受了50至54格雷的放疗且未进行化疗。这些无肿瘤复发证据的儿童在放疗结束后18至36个月出现了严重的SNHL。虽然未观察到明确的听力图模式,但大多数患者听力较差的耳朵主要表现为高频SNHL,听力较好的耳朵听力波动,且无骨放射性坏死或耳部感染的证据。文献综述表明,耳蜗基底转的外毛细胞和耳蜗神经元损伤可能是听力损失的原因。放疗前进行听力评估以及放疗后至少3年的评估是明智的。